GreenLight Biosciences Fundraise: US$102M From Morningstar, Others
Malaysian government’s Xeraya Capital also participated in GreenLight Biosciences’ fundraise U.S.-based biotechnology company GreenLight Biosciences has raised $102 million in its Series D round fundraise from large Southeast Asian and American investors, the company announced in a statement. The oversubscribed round was led by Hong Kong-based Morningside Ventures, owned by the Chan family, the real-estate […]
GreenLight Biosciences Fundraise: US$102M From Morningstar, Others Read More »
Malaysian government’s Xeraya Capital also participated in GreenLight Biosciences’ fundraise U.S.-based biotechnology company GreenLight Biosciences has raised $102 million in its Series D round fundraise from large Southeast Asian and American investors, the company announced in a statement. The oversubscribed round was led by Hong Kong-based Morningside Ventures, owned by the Chan family, the real-estate


